A Study of Dosing Patterns and Costs in Patients With Spinal Muscular Atrophy Receiving Disease Modifying Therapies
N/A
The aim of this study was to assess real-world dosing patterns, long-term h...
Status
Completed
Location
Novartis
Start Date
2024-11-06
Trial ID
NCT07378943
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
PHASE3
This study will evaluate the efficacy and safety of ocrelizumab in particip...
An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD
PHASE3
The aim of this clinical study is to assess the long-term efficacy and safe...